Concepedia

Susan D’Aloisio

SD

Statistics

Publications

4

Citations

503

H-Index

4

Active since

2000

Affiliations

BC Cancer Agency(Current)

Susan D’Aloisio is an author at BC Cancer Agency specializing in pharmacology, chemotherapy, and medicine.

Publications per year

2000–2005

4

Publications

4

A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer.

K. N., Martin Gleave, Richard Klasa et al. · PubMed · 2001 · 192 citations

Medicine, Oncology, Pharmacology +17

A Phase II, Pharmacokinetic, and Biological Correlative Study of Oblimersen Sodium and Docetaxel in Patients with Hormone-Refractory Prostate Cancer

Anthony W. Tolcher, Kim Chi, John G. Kuhn et al. · Clinical Cancer Research · 2005 · 165 citations

Medicine, Pharmacokinetics, Pharmacology +17

Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks

Alison Davis, Karen A. Gelmon, Lillian L. Siu et al. · Investigational New Drugs · 2003 · 91 citations

Medicine, Pharmacokinetics, Pharmacology +11

Phase I Dose-Finding Study of a New Taxane, RPR 109881A, Administered as a One-Hour Intravenous Infusion Days 1 and 8 to Patients With Advanced Solid Tumors

Karen A. Gelmon, Jean Latreille, Anthony W. Tolcher et al. · Journal of Clinical Oncology · 2000 · 55 citations

Pharmacy, Oncology, Pharmacology +17

1–4 of 4